Coronavirus resurges as Americans ease into reopenings
CBS News' Mark Strassmann reports on the latest developments on COVID-19 across the country.
Publication date: Available online 4 July 2020Source: Molecular and Cellular ProbesAuthor(s): Raheleh Torabi, Reza Ranjbar, Mehrdad Halaji, Mohammad Heiat
Publication date: 4 July 2020Source: New Scientist, Volume 247, Issue 3289Author(s): Adam Vaughan
Publication date: 4 July 2020Source: New Scientist, Volume 247, Issue 3289Author(s): Clare Wilson
Publication date: 4 July 2020Source: New Scientist, Volume 247, Issue 3289Author(s): Michael Le Page
Publication date: 4 July 2020Source: New Scientist, Volume 247, Issue 3289Author(s): Michael Marshall
Fourth of July weekend in US sees cases surging; WHO changes timeline of how it was alerted to virus; housing estates in Melbourne locked down. Follow developments liveWhat we ’re learning about Covid as US states open upHow Victoria ’s outbreak divided AustraliaScotland and Wales attack UK government ’s shambolic travel changes11.58pmBSTHere the latest key developments at a glance:11.51pmBSTA weeklyKansas newspaper whose publisher is a county Republican party chairman posted a cartoon on its Facebook page likening the Democratic governor ’s order requiring people to wear masks in public to the roun...
“The unparalleled and pervasive nature of the evolving COVID-19 pandemic has touched all of us in some way. There is limited, albeit growing, research on the mental health effects of disasters. A recent review article pointed out the potentially negative consequences of prolonged quarantine, while other research from Wuhan, China, highlighted the impact of COVID-19, particularly amongst healthcare personnel. Psychiatrists and […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Authors: Ambrosino P, Di Minno A, Maniscalco M, Di Minno MND Abstract The rapidly increasing number of studies on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) indicate that this viral agent can cause the coronavirus disease 2019 (COVID-19), a syndrome with a wide spectrum of clinical presentations, ranging from a mild disease with flu-like symptoms to a life-threatening condition that requires specialized management at Intensive Care Units (ICU). Critical patients with COVID-19 have a high risk of thromboembolic complications, as expressed by a Padua prediction score always ≥4. Moreover...
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospitalCoronavirus – latest updatesSee all our coronavirus coverageThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drughydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality.The setback came as WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The US accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.Continue reading...
Even with more than 500,000 dead worldwide, scientists are struggling to learn how often the virus kills. Here ’s why.